Subhash Chandra Ghosh et al.
FULL PAPERS
N-(1-Methylhexyl)hexanamide: Purified by silica gel
column chromatography (hexane:EA 3:1, Rf =0.30) to
afford a colorless liquid. Isolated yields: conditions A: 45%,
conditions B: 69%. It contains 1:1.4 mixture of two rotam-
ers. HR-MS (ESI):
m/z=240.1391 [MH+], calcd. for C16H18NO: 240.1388.
1
1
Major rotamer: H NMR (CDCl3): d=7.31–7.21 (m, 9H),
conditions B: 60%. H NMR (CDCl3): d=5.71 (d, 1H, J=
7.10–7.08 (m, 1H), 4.60 (s, 2H), 3.78 (s, 2H), 2.88 (s, 3H);
13C NMR (CDCl3): d=171.3, 137.3, 135.0, 129.0, 128.9,
128.6, 128.1, 126.9, 126.4, 51.0, 41.3, 35.3.
7.7 Hz), 3.92–3.86 (m, 1H), 2.08 (t, 2H, J=7.3 Hz), 1.55 (p,
2H, J=7.7 Hz), 1.39–1.15 (m, 12H), 1.04 (d, 3H, J=
6.8 Hz), 0.84–0.80 (m, 6H); 13C NMR (CDCl3): d=172.6,
45.1, 37.0, 36.9, 31.8, 31.5, 25.8, 25.7, 22.7, 22.5, 21.1, 14.1,
14.0; HR-MS (ESI): m/z=214.2169 [MH+], calcd. for
C13H28NO: 214.2171.
1
Minor rotamer: H NMR (CDCl3): d=7.31–7.21 (m, 9H),
7.10–7.08 (m, 1H), 4.51 (s, 2H), 3.75 (s, 2H), 2.94 (s, 3H);
13C NMR (CDCl3): d=171.6, 136.5, 135.2, 129.0, 128.9,
128.8, 127.7, 127.4, 126.9, 53.7, 40.9, 34.1.
N-Benzyl-2-methylbutanamide: Purified by silica gel
column chromatography (hexane:EA 3:1, Rf =0.26) to
afford a white solid. Isolated yields: conditions A: 77%,
conditions B: 70%. 1H NMR (CDCl3): d=7.30–7.25 (m,
5H), 6.19 (bs, 1H), 4.45–4.37 (m, 2H), 2.19–2.12 (m, 1H),
1.73–1.62 (m, 1H), 1.48–1.41 (m, 1H), 1.15 (d, 3H, J=
N,2-Diphenylacetamide: Purified by silica gel column
chromatography (hexane:EA 4:1, Rf =0.31) to afford a
white solid. Isolated yields: conditions A: 19%, conditions
B: 25%. 1H NMR (CDCl3): d=7.42–7.24 (m, 10H), 7.12–
7.05 (m, 1H), 3.71 (s, 2H); 13C NMR (CDCl3): d=169.4,
137.8, 134.6, 129.7, 129.4, 129.1, 127.8, 124.6, 120.0, 45.0;
HR-MS (ESI): m/z=212.1079 [MH+], calcd. for C14H14NO:
212.1075.
6.8 Hz), 0.91 (t, 3H, J=7.2 Hz); 13C NMR
ACTHNUTRGNEU(GN CDCl3): d=
176.6, 138.7, 128.7, 127.8, 127.4, 43.4, 43.2, 27.4, 17.7, 12.1;
HR-MS (ESI): m/z=192.1384 [MH+], calcd. for C12H18NO:
192.1388.
N-Benzylpivalamide: Purified by silica gel column chro-
matography (hexane:EA 3:1, Rf =0.26) to afford a white
solid. Isolated yields: conditions A: 19%, conditions B:
19%. 1H NMR (CDCl3): d=7.35–7.25 (m, 5H), 5.93 (bs,
1H), 4.43 (d, 2H, J=5.9 Hz), 1.24 (s, 9H); 13C NMR
(CDCl3): d=178.5, 138.8, 128.9, 127.8, 127.6, 43.8, 38.9, 27.8;
HR-MS (ESI): m/z=192.1390 [MH+], calcd. for C12H18NO:
192.1388.
Piperidin-2-one: Purified by silica gel column chromatog-
raphy (CH2Cl2:MeOH 19:1, Rf =0.30) to afford a white
solid. Isolated yields: conditions A: 92%, conditions B:
94%. 1H NMR (CDCl3): d=7.52 (bs, 1H), 3.19–3.16 (m,
2H), 2.21 (t, 2H, J=6.4 Hz), 1.72–1.60 (m, 4H); 13C NMR
(CDCl3): d=172.9, 42.0, 31.4, 22.1, 20.8; HR-MS (ESI):
m/z=100.0761 [MH+], calcd. for C5H10NO: 100.0762.
Phenyl(piperidin-1-yl)methanone: Purified by silica gel
column chromatography (hexane:EA 3:1, Rf =0.31) to
Acknowledgements
We are grateful to the National Research Foundation for gen-
erous support of this research and Nanyang Technological
University for graduate student scholarships to Z.Y. and X.X.
We thank Professor Sunggak Kim for helpful discussion on
the manuscript.
References
[1] a) T. Cupido, J. Tulla-Puche, J. Spengler, F. Albericio,
Curr. Opin. Drug Discovery Dev. 2007, 10, 768; b) J. W.
Bode, Curr. Opin. Drug Discovery Dev. 2006, 9, 765;
c) J. M. Humphrey, A. R. Chamberlin, Chem. Rev.
1997, 97, 2243.
[2] a) S.-Y. Han, Y.-A. Kim, Tetrahedron 2004, 60, 2447;
b) C. A. G. N. Montalbetti, V. Falque, Tetrahedron
2005, 61, 10827; c) E. Valeur, M. Bradley, Chem. Soc.
Rev. 2009, 38, 606; d) R. C. Larock, Comprehensive Or-
ganic Transformations, VCH, New York, 1999.
[3] a) E. Saxon, C. R. Bertozzi, Science 2000, 287, 2007;
b) F. Damkaci, P. DeShong, J. Am. Chem. Soc. 2003,
125, 4408; c) Y. G. Gololobov, L. F. Kasukhin, Tetrahe-
dron 1992, 48, 1353; d) Z. Pianowski, K. Gorska, L.
Oswald, C. A. Merten, N. Winssinger, J. Am. Chem.
Soc. 2009, 131, 6492.
[4] a) T. Ribelin, C. E. Katz, D. G. English, S. Smith, A. K.
Manukyan, V. W. Day, B. Neuenswander, J. L. Poutsma,
J. Aub, Angew. Chem. 2008, 120, 6329; Angew. Chem.
Int. Ed. 2008, 47, 6233; b) S. Lang, J. A. Murphy, Chem.
Soc. Rev. 2006, 35, 146.
afford a sticky liquid. Isolated yields: conditions A: 64%,
1
conditions B: 80%. H NMR (CDCl3): d=7.37
G
(bs, 2H), 3.33 (bs, 2H), 1.66–1.50 (m, 6H); 13C NMR
(CDCl3): d=170.3, 136.5, 129.4, 128.4, 126.8, 48.8, 43.1, 26.6,
25.7, 24.6; HR-MS (ESI): m/z=190.1232 [MH+], calcd. for
C12H16NO: 190.1232.
1-Morpholino-2-phenylethanone: Purified by silica gel
column chromatography (hexane:EA 1:2, Rf =0.32) to
afford a white solid. Isolated yields: conditions A: 63%,
conditions B: 90%. 1H NMR (CDCl3): d=7.34–7.22 (m,
5H), 3.73 (s, 2H), 3.63 (s, 4H), 3.48–3.41 (m, 4H); 13C NMR
(CDCl3): d=169.7, 134.9, 128.9, 128.6, 127.0, 66.8, 66.5, 46.6,
42.2, 40.9; HR-MS (ESI): m/z=206.1182 [MH+], calcd. for
C12H16NO2: 206.1181.
N-Benzylbenzamine: Purified by silica gel column chro-
matography (hexane:EA 2:1, Rf =0.29) to afford a white
solid. Isolated yields: conditions A: 78%, conditions B:
93%. 1H NMR (CDCl3): d=7.80–7.78 (m, 2H), 7.50–7.30
(m, 8H), 6.48 (bs, 1H), 4.64 (d, 2H, J=5.9 Hz); 13C NMR
(CDCl3): d=167.5, 138.4, 134.5, 131.7, 128.9, 128.7, 128.0,
127.7, 127.2, 44.3; HR-MS (ESI): m/z=212.1071 [MH+],
calcd. for C14H14NO: 212.1075.
[5] a) N. A. Owston, A. J. Parker, J. M. J. Williams, Org.
Lett. 2007, 9, 3599; b) M. Hashimoto, Y. Obora, S. Sa-
kaguchi, Y. Ishii, J. Org. Chem. 2008, 73, 2894.
[6] a) J. R. Martinelli, T. P. Clark, D. A. Watson, R. H.
Munday, S. L. Buchwald, Angew. Chem. 2007, 119,
8612; Angew. Chem. Int. Ed. 2007, 46, 8460; b) P. Na-
nayakkara, H. Alper, Chem. Commun. 2003, 2384.
N-Benzyl-N-methyl-2-phenylacetamide: Purified by silica
gel column chromatography (hexane:EA 4:1, Rf =0.26) to
afford a colorless liquid. Isolated yields: conditions A: 58%,
2648
ꢂ 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Adv. Synth. Catal. 2009, 351, 2643 – 2649